From the 2010 Annual Report © Novartis

Photo by Steve McCurry


Faced with dramatic changes in the industry, life science leaders Sandoz and Ciba-Geigy were convinced it would be impossible to survive independently, and moved to merge.

The context for developing the new brand required strict secrecy, given that the talks would result in the largest merger in history at that time. Ken led the creative team, working directly with Daniel Vasella, CEO-designate, and his team in Basel where both companies had been established in the 19th century. The name chosen was derived from the Latin for new skills. And together with the symbol as visual reinterpretation of the pharmacologist’s tools, helped express the vision for the company as the leader in life sciences.

Today, this name and identity represent one of the industry’s strongest players and world’s most respected companies.